In ARDS patients, TGFβ1 increases in the parenchyma and blood in the early stages, and in the later stage, chronic inflammation dominated by TGFβ signaling and Immunglobulin-A2 production develops, which induces fibrosis [82]. Here, TGFB1 is linked to acute respiratory distress syndrome.